# Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System

> **NCT00528385** · NA · COMPLETED · sponsor: **Medical University of Gdansk**

## Conditions studied

- Chronic Kidney Disease
- Proteinuria

## Interventions

- **DRUG:** Spironolactone (Spironol) 25 mg

## Key facts

- **NCT ID:** NCT00528385
- **Lead sponsor:** Medical University of Gdansk
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2007-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00528385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00528385, "Optimalization of Nephroprotection Using Agents Inhibiting Renin-Angiotensin-Aldosterone System". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00528385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*